Positions

Selected Publications

Academic Article

Year Title Altmetric
2016 Risk stratification model to detect early pulmonary disease in infants with cystic fibrosis diagnosed by newborn screening.  Pediatric Pulmonology.  51:1168-1176. 2016
2015 Adherence to airway clearance therapy in pediatric cystic fibrosis: Socioeconomic factors and respiratory outcomes.  Pediatric Pulmonology.  50:1244-1252. 2015
2014 ESCF care guidelines beyond Europe.  Journal of Cystic Fibrosis.  13:359-360. 2014
2014 Spiritual coping predicts 5-year health outcomes in adolescents with cystic fibrosis.  Journal of Cystic Fibrosis.  13:593-600. 2014
2014 Sustained improvement in nutritional outcomes at two paediatric cystic fibrosis centres after quality improvement collaboratives.  BMJ Quality and Safety.  23. 2014
2011 Rapid onset of iatrogenic adrenal insufficiency in a patient with cystic fibrosis-related liver disease treated with inhaled corticosteroids and a moderate CYP3A4 inhibitor..  Annals of Pharmacotherapy.  45. 2011
2011 Rapid onset of iatrogenic adrenal insufficiency in a patient with cystic fibrosis-related liver disease treated with inhaled corticosteroids and a moderate CYP3a4 inhibitor.  Annals of Pharmacotherapy.  45. 2011
2010 Baseline characteristics and factors associated with nutritional and pulmonary status at enrollment in the cystic fibrosis EPIC observational Cohort.  Pediatric Pulmonology.  45:934-944. 2010
2010 Cystic fibrosis pulmonary guidelines: Pulmonary complications: Hemoptysis and pneumothorax.  American Journal of Respiratory and Critical Care Medicine.  182:298-306. 2010
2010 Improving the quality of care for patients with cystic fibrosis.  Current Opinion in Pediatrics.  22:296-301. 2010
2009 Cystic fibrosis care in Chile.  Current Opinion in Pulmonary Medicine.  15:632-637. 2009
2008 Creating a culture of improvement: experience of a pediatric cystic fibrosis center..  Journal of Nursing Care Quality.  23:115-120. 2008
2008 Genetic and reproductive knowledge among adolescents and adults with cystic fibrosis.  Chest.  133:1533. 2008
1996 Nitric oxide regulation of superoxide-dependent lung injury: Oxidant- protective actions of endogenously produced and exogenously administered nitric oxide.  Free Radical Biology and Medicine.  21:43-52. 1996
1995 Oxygen Radical-Nitric Oxide Reactions in Vascular Diseases.  Advances in Pharmacology.  34:45-69. 1995
1995 Pulmonary alveolar epithelial inducible NO synthase gene expression: Regulation by inflammatory mediators 1995
1993 Mycoplasmal infections. Epidemiology, immunology, diagnostic techniques, and therapeutic strategies.  Immunology and Allergy Clinics of North America.  13:43-57. 1993

Principal Investigator On

  • Cystic Fibrosis Training Network: Latin America  awarded by Cystic Fibrosis Foundation 2018 - 2021
  • Learning Network: Implementation Phase  awarded by CHILDREN'S HOSPITAL MEDICAL CENTER (CINCINNATI) 2020
  • Cystic Fibrosis Screening of Newborn Infants  awarded by ALABAMA DEPARTMENT OF PUBLIC HEALTH 2019 - 2020
  • Optimization of the Alabama CF Newborn Screening Program  awarded by Cystic Fibrosis Foundation 2018 - 2020
  • UAB Cystic Fibrosis Center for Care, Teaching, and Research  awarded by Cystic Fibrosis Foundation 2019 - 2020
  • A CF C3N Care Model of the Future: Proposal for Piloting a Learning Health System  awarded by CHILDREN'S HOSPITAL & REGIONAL MEDICAL CENTER 2016 - 2019
  • Cystic Fibrosis Newborn Screening  awarded by ALABAMA DEPARTMENT OF PUBLIC HEALTH 2018 - 2019
  • UAB Cystic Fibrosis Center for Care, Teaching and Research  awarded by Cystic Fibrosis Foundation 2018 - 2019
  • The EPIC Observational Study: Longitudinal Assessment of Risk Factors for and Impact of Pseudomonas Aeruginosa Acquisition and Early Anti-Pseudomonal Treatment in Children with CF  awarded by CHILDREN'S HOSPITAL & REGIONAL MEDICAL CENTER 2014 - 2019
  • Transformative Integrated Model for Continuous CF Care  awarded by Cystic Fibrosis Foundation 2014 - 2019
  • Implementation of the Depression and Anxiety Guideline: Award for a Mental Health Coordinator  awarded by Cystic Fibrosis Foundation 2016 - 2018
  • CF Center in Chile, Pilot and Feasibility Program  awarded by Cystic Fibrosis Foundation 2014 - 2018
  • Cystic Fibrosis Screening for Newborn Infants  awarded by ALABAMA DEPARTMENT OF PUBLIC HEALTH 2017 - 2018
  • UAB Cystic Fibrosis Center for Care, Teaching, and Research  awarded by Cystic Fibrosis Foundation 2017 - 2018
  • A Multi-Center Study of a New Method of Sweat Testing: The CF Quantum Sweat Test  awarded by University of Wisconsin-Madison 2015 - 2017
  • Cystic Fibrosis Screening for Newborn Infants  awarded by ALABAMA DEPARTMENT OF PUBLIC HEALTH 2016 - 2017
  • UAB Cystic Fibrosis Center for Care, Teaching, and Research  awarded by Cystic Fibrosis Foundation 2016 - 2017
  • Cystic Fibrosis Screening for Newborn Infants  awarded by ALABAMA DEPARTMENT OF PUBLIC HEALTH 2015 - 2016
  • UAB Cystic Fibrosis Center for Care, Teaching, and Research  awarded by Cystic Fibrosis Foundation 2015 - 2016
  • Cystic Fibrosis Screening for Newborn Infants  awarded by ALABAMA DEPARTMENT OF PUBLIC HEALTH 2014 - 2015
  • UAB Cystic Fibrosis Center for Care, Teaching and Research  awarded by Cystic Fibrosis Foundation 2014 - 2015
  • Cystic Fibrosis Screening for Newborn Infants  awarded by ALABAMA DEPARTMENT OF PUBLIC HEALTH 2013 - 2014
  • UAB Cystic Fibrosis Center for Care, Teaching and Research  awarded by Cystic Fibrosis Foundation 2013 - 2014
  • The EPIC Observational Study: Longitudinal Assessment of Risk Factors for and Impact of Pseudomonas Aeruginosa Acquisition and Early Anti-Pseudomonal Treatment in Children with CF  awarded by CHILDREN'S HOSPITAL & REGIONAL MEDICAL CENTER 2009 - 2014
  • I C.A.R.E. - I Change Adherence and Raise Expectations  awarded by University of Miami 2010 - 2013
  • Cystic Fibrosis Screening for Newborn Infants  awarded by ALABAMA DEPARTMENT OF PUBLIC HEALTH 2012 - 2013
  • Pediatric Cystic Fibrosis Center for Care, Teaching and Research  awarded by Cystic Fibrosis Foundation 2004 - 2013
  • Cystic Fibrosis Screening for Newborn Infants  awarded by ALABAMA DEPARTMENT OF PUBLIC HEALTH 2011 - 2012
  • Cystic Fibrosis Screening for Newborn Infants  awarded by ALABAMA DEPARTMENT OF PUBLIC HEALTH 2010 - 2011
  • UAB CF Research and Translation Core Center - Pilot Supplement  awarded by National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS 2009 - 2011
  • Private Grant  awarded by VERTEX PHARMACEUTICALS, INC. 2009 - 2011
  • The Effect of Formula Fortified with Docosahexaenoic Acid (DHA) on Infants with Cystic Fibrosis  awarded by UNIVERSITY OF MASSACHUSETTS (WORCESTER) 2008 - 2011
  • Early Recognition and Intervention for Acute Pulmonary Exacerbation in CF  awarded by Cystic Fibrosis Foundation 2009 - 2010
  • Cystic Fibrosis Screening for Newborn Infants  awarded by ALABAMA DEPARTMENT OF PUBLIC HEALTH 2009 - 2010

    • Investigator On

  • Childhood Pulmonary and Related Outcomes after Perinatal Exposure to Adjunctive Azithromycin Prophylaxis For Cesarean Delivery (C/SOAP Follow-up Study)  awarded by National Institute of Child Health and Human Development/NIH/DHHS 2020 - 2024
  • Technology-Enabled Patient Support System for Self-Management of Pediatric Cystic Fibrosis  awarded by KAUL PEDIATRIC RESEARCH INSTITUTE 2019 - 2021
  • Prevalence and Significance of Staphylococcus Aureus Small–Colony Variants  awarded by SEATTLE CHILDREN'S RESEARCH INSTITUTE 2014 - 2018
  • Development of Standardized Measures of Barriers to Treatment Adherence: Field Testing and Psychometric Validation  awarded by CHILDREN'S HOSPITAL (BOSTON) 2017
  • Success with Therapies Research Consortium  awarded by Cystic Fibrosis Foundation 2014 - 2017
  • Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerbations in Patients with Cystic Fibrosis  awarded by SEATTLE CHILDREN'S RESEARCH INSTITUTE 2013 - 2016
  • Private Grant  awarded by VERTEX PHARMACEUTICALS, INC. 2013 - 2016
  • Private Grant  awarded by GlaxoSmithKline 2014 - 2015
  • Private Grant  awarded by Gilead Sciences 2012 - 2015
  • Private Grant  awarded by VERTEX PHARMACEUTICALS, INC. 2013 - 2014
  • Private Grant  awarded by VERTEX PHARMACEUTICALS, INC. 2013 - 2014
  • Private Grant  awarded by VERTEX PHARMACEUTICALS, INC. 2012 - 2013
  • UAB CF Research and Translation Core Center  awarded by National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS 2007 - 2012

    • Education And Training

  • Doctor of Medicine, 1983
  • University of Maryland Medical System, Residency 1991
  • University Hospital - Santiago, Residency 1989
  • UAB Hospital, Postdoctoral Fellowship 1994

    • Full Name

  • Hector Gutierrez